Wellington Management Group
ELVN icon

Wellington Management Group’s Enliven Therapeutics ELVN Stock Holding History

Wellington Management Group’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.88M Buy
150,126
+20,250
+16% +$561K ﹤0.01% 1376
2025
Q4 		$2M Buy
129,876
+21,316
+20% +$425K ﹤0.01% 1603
2025
Q3 		$2.22M Buy
108,560
+14,548
+15% +$293K ﹤0.01% 1605
2025
Q2 		$1.89M Buy
94,012
+9,312
+11% +$176K ﹤0.01% 1591
2025
Q1 		$1.67M Buy
84,700
+3,784
+5% +$81.4K ﹤0.01% 1596
2024
Q4 		$1.82M Buy
80,916
+10,746
+15% +$279K ﹤0.01% 1588
2024
Q3 		$1.79M Buy
70,170
+36,267
+107% +$840K ﹤0.01% 1568
2024
Q2 		$792K Buy
+33,903
New +$714K ﹤0.01% 1719

Other funds holding ELVN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return